| Literature DB >> 33168619 |
Yuri Zilberter1,2, Tanya Zilberter3.
Abstract
The ketogenic diet (KD) has been successfully used for a century for treating refractory epilepsy and is currently seen as one of the few viable approaches to the treatment of a plethora of metabolic and neurodegenerative diseases. Empirical evidence notwithstanding, there is still no universal understanding of KD mechanism(s). An important fact is that the brain is capable of using ketone bodies for fuel. Another critical point is that glucose's functions span beyond its role as an energy substrate, and in most of these functions, glucose is irreplaceable. By acting as a supplementary fuel, ketone bodies may free up glucose for its other crucial and exclusive function. We propose that this glucose-sparing effect of ketone bodies may underlie the effectiveness of KD in epilepsy and major neurodegenerative diseases, which are all characterized by brain glucose hypometabolism.Entities:
Keywords: aerobic glycolysis; antioxidant system; glucose metabolism; glycogen; ketogenic diet; ketosis
Mesh:
Substances:
Year: 2020 PMID: 33168619 PMCID: PMC7768283 DOI: 10.1523/ENEURO.0303-20.2020
Source DB: PubMed Journal: eNeuro ISSN: 2373-2822